Mostrando 10 resultados de: 27
Subtipo de publicación
Other(27)
Publisher
Elsevier(11)
AMER ASSOC BLOOD BANKS(1)
Luis Henrique Almeida Castro(1)
Observatori de Bioètica i Dret(1)
Public Library of Science(1)
Área temáticas
Enfermedades(15)
Farmacología y terapéutica(13)
Microorganismos, hongos y algas(13)
Ganadería(10)
Medicina forense; incidencia de enfermedades(5)
Área de conocimiento
Inmunología(11)
Infección(8)
Medicina veterinaria(7)
Farmacología(3)
Microbiología(3)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(27)
ODS 17: Alianzas para lograr los objetivos(24)
ODS 1: Fin de la pobreza(1)
ODS 8: Trabajo decente y crecimiento económico(1)
ODS 9: Industria, innovación e infraestructura(1)
Origen
google(27)
APLICAÇÃO DE GENOGRAMA EM FAMÍLIAS COM CASOS DE HANSENÍASE NO LESTE DE MINAS GERAIS PARA AUXÍLIO NA CARACTERIZAÇÃO CLÍNICA-SÓCIO-DEMOGRÁFICA
OtherAbstract:Palabras claves:Autores:Gulnara Borja-CabreraFuentes:googleAvaliação da farmacoterapia empregada em residentes de uma Instituição de Longa Permanência para Idosos
OtherAbstract: O fenômeno das interações medicamentosas constitui na atualidade um dos temas mais importantes relacPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleAcylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis
OtherAbstract: The adjuvant of the FML-vaccine against murine and canine visceral leishmaniasis, the Riedel de HaenPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleAdaptive immunity against Leishmania nucleoside hydrolase maps its C-terminal domain as the target of the CD4+ T cell–driven protective response
OtherAbstract: Nucleoside hydrolases (NHs) show homology among parasite protozoa, fungi and bacteria. They are vitaPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleEffective immunotherapy against canine visceral leishmaniasis with the FML-vaccine
OtherAbstract: The potential effect of the fucose mannose ligand (FML)-vaccine on immunotherapy of canine visceralPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleHuman Visceral Leishmaniasis: Ethical and Legal Reflections on the Canine Reservoir Control in Brazil
OtherAbstract: Brazil currently faces difficulties in combating human visceral leishmaniasis. According to the WorlPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleFML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine
OtherAbstract: The Leishmania donovani glycoprotein fraction, known as FML, successfully underwent preclinical andPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleEvaluation of pharmacotherapy used in residents of a Long Stay Institution for the Elderly
OtherAbstract: The phenomenon of drug interactions is today one of the most important issues related to the consumpPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleEvaluation of the inhibiting potential of hydrolase nucleoside from Leishmania donovani by nuclear magnetic resonance; Avaliacao de potenciais inibidores da nucleosideo …
OtherAbstract: Subject: 37 INORGANIC, ORGANIC, PHYSICAL AND ANALYTICAL CHEMISTRY; CHEMICAL PREPARATION; CHEMICAL REPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleIgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis.
OtherAbstract: Canine antibody I-G. IgG1 and IgG2 anti-FML responses were investigated in dogs vaccinated with thePalabras claves:Autores:Gulnara Borja-CabreraFuentes:google